Is Precision Optics Corporation, Inc. Common stock (POCI) overvalued? · rev $19.1M
Precision Optics Corporation, Inc. Common stock (POCI) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether Precision Optics Corporation, Inc. Common stock (POCI) looks expensive on cached numbers — not a short thesis.
Latest reported POCI revenue for 2025-06-30 was $19.1M. Net income was -$5.8M. Revenue was down 0.1% from 2024-06-30 to 2025-06-30. POCI currently screens at market cap $63.4M.
POCI currently screens at market cap $63.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next POCI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the POCI stock page for the full model, not this heading.
Not investment advice.